NOT FOR REPRINT
Page Printed from: treasuryandrisk.com/author/profile/laura-davison-lynnley-browning-allyson-versprille
Sign In To follow
Rule change would be a boon to tech and pharma companies.
Corporate America remains “in limbo” as IRS punts on foreign tax issue.
